Register Login

All Posts

Hemostasis Assay Statistical Variability

Here is an open-access commentary that addresses concerns about hemostasis assay statistical variability as it relates to clinical significance. Click: Mullier F, Gouin-Thibault I, Meijer P, et al. Time to integrate measurement uncertainty in method comparison and interpretation of hemostasis laboratory assays. Res Practice Thromb Hemost 2025: 9, https://doi.org/10.1016/j.rpth.2025.102993. For a two-part discussion about hemostasis quality assurance […]
read more

Charcoal Adsorbents Remove Anti-FXIa Interference

My (Geo) audio PowerPoint, Managing Direct Oral Anticoagulants, was posted in 2021. One of the final slides indicates experimental anticoagulant formulations designed to suppress FXI activation, aiming to reduce thrombotic risk without increasing the risk of bleeding. Click open-access article Buckley GT, Crowley MP, Harte JV. Interferences associated with the factor XIa inhibitors asundexian and […]
read more

July 2025 CAP Today: A Deep Dive Into Key Hemostasis Testing Variables

Click A Deep Dive Into Key Hemostasis Testing Variables for an in-depth review of preanalytical hemostasis specimen concerns. The CAP article features Andrew Goodwin MD, professor, Department of Pathology and Laboratory Medicine, University of Vermont Larner College of Medicine, and medical director of the thrombosis and hemostasis section, University of Vermont Medical Center; and Dr. […]
read more